Background Oral cavity and oropharyngeal cancers are frequently described as part of a
group of oral cancers or head and neck cancer. Treatment of oral cavity cancer is generally …

Abstract Background and purpose The Meta-Analysis of Chemotherapy in squamous cell
Head and Neck Cancer (MACH-NC) demonstrated that concomitant chemotherapy (CT) …

Background Randomised, controlled trials and meta-analyses have shown the survival
benefit of concomitant chemoradiotherapy or hyperfractionated radiotherapy in the treatment …

Locally advanced stages of squamous cancers of the head and neck (LAHNCs) acquire
high propensity for local and systemic relapse. Addition of systemic therapy as an induction …

Background Neo-adjuvant chemotherapy (NACT) followed by response assessment is the
standard treatment algorithm for locally advanced oral cavity squamous cell carcinomas …

Background/Aim: Chemoradiotherapy (CRT) with high-dose cisplatin has become the
standard of care for larynx preservation in patients with locally advanced squamous cell …

Abstract Background Sequential treatment of Panitumumab (Pb) plus Paclitaxel (Px) as
induction treatment (IT) followed by concurrent bioradiotherapy (Bio–RT) with Pb may be an …

Background Patients with early-stage head and neck squamous cell carcinoma (HNSCC)
are treated using a single-modality approach that involves either surgery (S) or radiotherapy …

Management of locally advanced OSCC is multimodal. No single therapy has been proved
to be efficacious. However there is a trend towards surgical intervention in operable disease …

Purpose HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) is a distinct
disease from other head and neck tumors. This guideline provides evidence-based …